Ions Invest Limited - Accounts to registrar - small 17.1.1

Ions Invest Limited - Accounts to registrar - small 17.1.1


IRIS Accounts Production v17.1.1.60 04280886 director 1.1.16 31.12.16 31.12.16 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure042808862015-12-31042808862016-12-31042808862016-01-012016-12-31042808862014-12-31042808862015-01-012015-12-31042808862015-12-3104280886ns15:EnglandWales2016-01-012016-12-3104280886ns14:PoundSterling2016-01-012016-12-3104280886ns10:Director12016-01-012016-12-3104280886ns10:PrivateLimitedCompanyLtd2016-01-012016-12-3104280886ns10:SmallEntities2016-01-012016-12-3104280886ns10:AuditExempt-NoAccountantsReport2016-01-012016-12-3104280886ns10:SmallCompaniesRegimeForAccounts2016-01-012016-12-3104280886ns10:FullAccounts2016-01-012016-12-3104280886ns10:CompanySecretary12016-01-012016-12-3104280886ns10:RegisteredOffice2016-01-012016-12-3104280886ns5:CurrentFinancialInstruments2016-12-3104280886ns5:CurrentFinancialInstruments2015-12-3104280886ns5:ShareCapital2016-12-3104280886ns5:ShareCapital2015-12-3104280886ns5:SharePremium2016-12-3104280886ns5:SharePremium2015-12-3104280886ns5:RetainedEarningsAccumulatedLosses2016-12-3104280886ns5:RetainedEarningsAccumulatedLosses2015-12-3104280886ns5:CostValuation2015-12-3104280886ns5:AdditionsToInvestments2016-12-3104280886ns5:CostValuation2016-12-31


REGISTERED NUMBER: 04280886 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2016

for

Ions Invest Limited

Ions Invest Limited (Registered number: 04280886)






Contents of the Financial Statements
for the Year Ended 31 December 2016




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Ions Invest Limited

Company Information
for the Year Ended 31 December 2016







DIRECTOR: Peter James Jackson





SECRETARY: CBC Company Secretary Limited





REGISTERED OFFICE: 126 Aldersgate Street
London
EC1A 4JQ





REGISTERED NUMBER: 04280886 (England and Wales)






Ions Invest Limited (Registered number: 04280886)

Balance Sheet
31 December 2016

31.12.16 31.12.15
Notes £    £    £    £   
FIXED ASSETS
Investments 3 1,635,529 1,587,521

CURRENT ASSETS
Cash at bank 823 70,213

CREDITORS
Amounts falling due within one year 4 2,686,862 2,682,161
NET CURRENT LIABILITIES (2,686,039 ) (2,611,948 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,050,510 ) (1,024,427 )

CAPITAL AND RESERVES
Called up share capital 136,100 136,100
Share premium 69,706 69,706
Retained earnings (1,256,316 ) (1,230,233 )
SHAREHOLDERS' FUNDS (1,050,510 ) (1,024,427 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2016 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the
end of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 16 June 2017 and were signed by:





Peter James Jackson - Director


Ions Invest Limited (Registered number: 04280886)

Notes to the Financial Statements
for the Year Ended 31 December 2016

1. STATUTORY INFORMATION

Ions Invest Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

3. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 January 2016 2,808,186
Additions 48,008
At 31 December 2016 2,856,194
PROVISIONS
At 1 January 2016
and 31 December 2016 1,220,665
NET BOOK VALUE
At 31 December 2016 1,635,529
At 31 December 2015 1,587,521

The investment relates to a holding in Medesis Pharma. In the year the Company purchased 3,000 shares. As
at the balance sheet date the Company held 561,261 shares which represents 22.4% of the issued share
capital.

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.16 31.12.15
£    £   
Other creditors 307,663 302,962
Loan - shareholders 2,379,199 2,379,199
2,686,862 2,682,161